MusthInsider

Latest On Satsuma Pharmaceuticals, Inc (STSA):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-19 01:36 EST	News	Satsuma migraine therapy accepted for FDA review	N/A
2023-04-17 11:51 EST	News	Shin Nippon Biomedical agrees to acquire Satsuma Pharmaceuticals for $0.91 in cash per share	N/A
2023-03-29 03:27 EST	News	Satsuma Pharmaceuticals GAAP EPS of -$0.70	N/A
2022-11-16 01:31 EST	News	Satsuma cut to neutral at Mizuho following migraine drug failure	N/A
2022-11-14 15:38 EST	News	Satsuma crashes 80% as migraine therapy STS101 fails phase 3 trial	N/A
2022-11-04 08:50 EST	News	Satsuma Pharmaceuticals GAAP EPS of -$0.48	N/A
2022-10-10 17:31 EST	News	Satsuma stock surges 11% after SVB upgrades on potential positive data for migraine therapy STS-101	N/A
2022-09-20 22:38 EST	News	Satsuma stock rises as migraine therapy STS101 shows safety in phase 3 trial	N/A
2022-08-10 06:03 EST	News	Satsuma Pharmaceuticals GAAP EPS of -$0.52	N/A
2022-05-11 10:39 EST	News	Satsuma Pharmaceuticals GAAP EPS of -$0.49 in-line	N/A
2022-03-16 12:27 EST	News	Satsuma Pharmaceuticals GAAP EPS of -$0.49	N/A
2021-11-09 17:33 EST	News	Satsuma Pharmaceuticals EPS beats by $0.09	N/A
2021-11-07 23:13 EST	News	Satsuma Pharmaceuticals: Sizing Up This One Trick Pony	N/A
2021-10-20 16:09 EST	News	Commodore Capital buys $780K shares in Satsuma Pharmaceuticals	N/A
2021-10-06 18:06 EST	News	GDS, APP, OSMT and STSA among after hours movers	N/A
2021-08-11 08:40 EST	News	Satsuma Pharmaceuticals EPS beats by $0.03	N/A
2021-07-29 05:24 EST	News	Satsuma randomizes first subject in late-stage STS101 migraine study	N/A
2021-07-22 02:44 EST	News	Satsuma shares surge on data from early-stage STS101 trial	N/A
2021-07-22 02:44 EST	News	STSA, AXLA, CVAC and CRBP among after-hours movers	N/A
2021-07-22 02:39 EST	News	Satsuma upgraded at Mizuho; predicts late-stage trial success	N/A
2021-04-05 15:31 EST	News	Focus on equipment makers as Citi unveils positive catalyst watch; Invitae upgraded on Softbank investment and more in today’s analyst action	N/A
2021-03-25 21:29 EST	News	Satsuma Pharmaceuticals EPS misses by $0.19	N/A
2021-03-07 14:55 EST	News	Satsuma: Launch Of 2nd Pivotal Trial For Migraine Med Ought To Cheer Share Price	N/A
2021-03-03 01:11 EST	Analyst Rating	The Analyst Target Price has increased from $4.5 to $7.25.	Buy
2021-03-02 00:30 EST	News	Satsuma stock surges on migraine treatment development plan update	N/A
2021-03-02 00:29 EST	News	Satsuma Pharmaceuticals announces private placement financing	N/A
2020-11-26 21:41 EST	Financials	Company financials have been released.	Neutral
2020-11-12 05:23 EST	Financials	Company financials have been released.	Neutral
2020-11-12 05:23 EST	Analyst Rating	The Analyst Target Price has decreased from $4.75 to $4.5.	Neutral
2020-11-11 05:05 EST	Earnings Estimate	An EPS average of -$0.55 is estimated for the quarter ending on March 31, 2021.	Buy
2020-11-11 01:23 EST	News	Satsuma Pharmaceuticals EPS beats by $0.02	N/A
2020-11-08 00:59 EST	Financials	Company financials have been released.	Neutral
2020-11-07 17:14 EST	Financials	Company financials have been released.	Neutral
2020-09-26 14:08 EST	Financials	Company financials have been released.	Neutral
2020-09-26 05:10 EST	News	Satsuma: Not All Over For Migraine Treatment Despite Trial Failure	N/A
2020-09-23 10:06 EST	Analyst Rating	The Analyst Target Price has decreased from $11.75 to $4.75.	Neutral
2020-09-17 06:21 EST	Financials	Company financials have been released.	Neutral
2020-09-14 21:18 EST	News	Satsuma Migraine Failure, And Other News: The Good, Bad And Ugly Of Biopharma	N/A
2020-09-14 09:32 EST	Analyst Rating	The Analyst Target Price has decreased from $26 to $11.75.	Neutral
2020-09-11 11:40 EST	News	Satsuma Pharma's STS101 flunks late-stage migraine study, shares down 84%	N/A
2020-09-11 11:37 EST	News	Analysts bail on Satsuma Pharma after STS101 flop	N/A
2020-09-11 09:34 EST	Analyst Rating	The Analyst Target Price has decreased from $33.75 to $26.	Neutral
2020-09-03 16:39 EST	Insider Trade	Thomas P. O'Neil has directly disposed of 750 shares and currently holds 0 shares.	Sell
2020-09-03 16:39 EST	Insider Trade	Thomas P. O'Neil has directly acquired 750 shares and currently holds 750 shares.	Buy
2020-09-03 16:39 EST	Insider Trade	DETLEF ALBRECHT has directly acquired 1,000 shares and currently holds 21,212 shares.	Buy
2020-09-03 16:39 EST	Insider Trade	DETLEF ALBRECHT has directly disposed of 1,000 shares and currently holds 20,212 shares.	Sell
2020-08-14 10:13 EST	Analyst Rating	The Analyst Target Price has increased from $33.5 to $33.75.	Buy
2020-08-14 10:13 EST	Financials	Company financials have been released.	Neutral
2020-08-14 05:46 EST	Financials	Company financials have been released.	Neutral
2020-08-13 01:30 EST	News	Satsuma Pharmaceuticals reports Q2 results	N/A

About Satsuma Pharmaceuticals, Inc (STSA):

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a novel therapeutic product for the acute treatment of migraine. Its lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in Phase III clinical trials and can be self-administered with a proprietary pre-filled, single-use, and nasal delivery device. The company was founded in 2016 and is headquartered in South San Francisco, California.

See Advanced Chart

General

Name Satsuma Pharmaceuticals, Inc
Symbol STSA
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 20
Fiscal Year EndDecember
IPO Date2019-09-13
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryPharmaceuticals
Gic SubIndustryRegional Banks
Web URLhttp://www.satsumarx.com

Valuation

Trailing PE 2.21
Price/Book (Most Recent Quarter) 2.49
Enterprise Value EBITDA 0.1

Financials

Most Recent Quarter 2020-09-30
Next Quarter EPS Estimate -$0.50
Return on Assets -27%
Return on Equity -46%
Earnings Per Share -$11.81
Revenue Per Share $0
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 203.16 million
EBITDA -12915000
Analyst Target Price $7.25
Book Value Per Share $7.03

Share Statistics

Shares Outstanding 31.52 million
Shares Float 2.62 million
% Held by Insiders 1084%
% Held by Institutions 56.83%
Shares Short 692542
Shares Short Prior Month 652951
Short Ratio 1.45
Short % of Float 10%
Short % of Shares Outstanding 4%

Technicals

52 Week High $36.11
52 Week Low $3.5
50 Day Moving Average 6.46
200 Day Moving Average 5.94

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Satsuma Pharmaceuticals, Inc (STSA) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Satsuma Pharmaceuticals, Inc (STSA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-09-30	2020-11-10	$N/A	-$0.69	-$0.73	5.48%
2020-06-30	2020-08-11	$N/A	-$0.65	-$0.70	6.57%
2020-03-31	2020-05-12	$N/A	-$0.68	-$0.67	-1.49%
2019-12-31	2020-03-10	$N/A	-$0.62	-$0.79	21.52%
2019-09-30	2019-11-12	$N/A	-$2.26	-$1.01	-123.76%

Satsuma Pharmaceuticals, Inc (STSA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019	Sep 30 2019
Research Development	N/A	N/A	9.65 million	9.15 million	7.44 million
Income Before Tax	N/A	N/A	-11.77 million	-10.81 million	-8.26 million
Selling General Administrative	N/A	N/A	2.52 million	2.13 million	1.03 million
Gross Profit	N/A	N/A	N/A	N/A	N/A
Ebit	N/A	N/A	-11.62 million	-11.28 million	-8.47 million
Operating Income	N/A	N/A	-12.17 million	-11.28 million	-8.47 million
Income Tax Expense	N/A	N/A	N/A	N/A	N/A
Total Revenue	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A
Total Other Income Expense Net	N/A	N/A	N/A	466000	210000
Net Income From Continuing Operations	N/A	N/A	-11.77 million	-10.81 million	-8.26 million
Net Income Applicable to Common Shares	-12.04 million	-11.27 million	N/A	-10.81 million	-8.26 million

Cash Flow:

Date	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019	Sep 30 2019
Investments	N/A	N/A	13.65 million	-54 million	-33.92 million
Change to Liabilities	773000	-967000	N/A	2.6 million	705000
Total Cash Flow from Investing Activities	20.52 million	19.69 million	N/A	-54.09 million	-33.9 million
Net Borrowings	-500000	-500000	N/A	-167000	N/A
Total Cash Flow from Financial Activities	N/A	N/A	-489000	6.37 million	75.26 million
Change to Operating Activities	-809000	1.22 million	N/A	800000	-4.2 million
Change in Cash	N/A	N/A	148000	-54.91 million	30.04 million
Total Cash from Operating Activities	-10.71 million	-10 million	-13.02 million	-7.19 million	-11.32 million
Depreciation	N/A	N/A	49000	39000	38000
Other Cash Flow from Investing Activities	N/A	N/A	N/A	N/A	N/A
Change to Inventory	N/A	N/A	N/A	N/A	N/A
Change to Account Receivables	N/A	N/A	N/A	N/A	N/A
Other Cash Flow from Financing Activities	50000	N/A	N/A	N/A	109000
Change to Net Income	1.3 million	960000	N/A	186000	399000
Capital Expenditures	N/A	N/A	283000	88000	-19000

Balance Sheet:

Date	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019	Sep 30 2019
Total Liabailities	N/A	N/A	9.73 million	10.94 million	9.42 million
Total Stockholder Equity	N/A	N/A	103.99 million	115.34 million	118.12 million
Other Current Liabilities	N/A	N/A	80000	N/A	N/A
Total Assets	N/A	N/A	113.72 million	126.28 million	127.54 million
Common Stock	2000	2000	N/A	2000	3000
Other Current Assets	N/A	N/A	N/A	N/A	N/A
Retained Earnings	-78.09 million	-66.04 million	-54.77 million	-43 million	-32.19 million
Other Liabilities	11000	13000	N/A	19000	66000
Other Assets	712000	568000	N/A	497000	76000
Cash	N/A	N/A	22.9 million	22.76 million	77.66 million
Total Current Liabilities	7.69 million	N/A	7.23 million	7.97 million	5.94 million
Other Stockholder Equity	85000	235000	N/A	17000	12000
Property, Plant & Equipment	1.45 million	1.31 million	N/A	832000	885000
Total Current Assets	90.05 million	N/A	108.88 million	114.74 million	126.58 million
Long Term Investments	N/A	N/A	3.34 million	10.2 million	N/A
Net Tangible Assets	82.99 million	93.93 million	N/A	115.34 million	118.12 million
Short Term Investments	N/A	N/A	77.88 million	84.94 million	41.28 million
Long Term Debt	N/A	N/A	2.48 million	2.95 million	3.42 million
Inventory	N/A	N/A	N/A	N/A	N/A
Accounts Payable	3.28 million	N/A	3.44 million	4.28 million	2.6 million

Satsuma Pharmaceuticals, Inc (STSA) Chart:

Satsuma Pharmaceuticals, Inc (STSA) News:

Below you will find a list of latest news for Satsuma Pharmaceuticals, Inc (STSA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Satsuma Pharmaceuticals, Inc (STSA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent

Latest STSA Trades:

Date	Shares	Price
Jun 13, 2022 6:33 PM EST	200	$3.1
Jun 13, 2022 6:33 PM EST	200	$3.1
Jun 13, 2022 6:33 PM EST	100	$3.1
Jun 13, 2022 7:00 PM EST	2500	$3.11
Jun 13, 2022 7:00 PM EST	800	$3.11

Satsuma Pharmaceuticals, Inc (STSA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date	Form Type	Form Name	Link
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2019-07-22	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1692830/000000000019011376/0000000000-19-011376-index.htm
2019-08-12	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1692830/000000000019012307/0000000000-19-012307-index.htm
2019-08-26	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1692830/000000000019012865/0000000000-19-012865-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023434/0000899243-19-023434-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023437/0000899243-19-023437-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023442/0000899243-19-023442-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023445/0000899243-19-023445-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023446/0000899243-19-023446-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023447/0000899243-19-023447-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023451/0000899243-19-023451-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023452/0000899243-19-023452-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023453/0000899243-19-023453-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023479/0000899243-19-023479-index.htm
2019-09-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023732/0000899243-19-023732-index.htm
2019-09-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023733/0000899243-19-023733-index.htm
2019-09-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023739/0000899243-19-023739-index.htm
2019-10-10	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1692830/000090221919000456/0000902219-19-000456-index.htm
2020-01-27	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1692830/000090221920000146/0000902219-20-000146-index.htm
2020-08-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1692830/000090221920000415/0000902219-20-000415-index.htm
2020-10-09	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1692830/000090221920000429/0000902219-20-000429-index.htm
2019-10-21	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1692830/000091957419006510/0000919574-19-006510-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1692830/000091957420001537/0000919574-20-001537-index.htm
2019-06-21	DRS	Draft Registration Statement	https://www.sec.gov/Archives/edgar/data/1692830/000095012319006096/0000950123-19-006096-index.htm
2019-08-02	DRS/A	Draft Registration Statement	https://www.sec.gov/Archives/edgar/data/1692830/000095012319006964/0000950123-19-006964-index.htm
2019-08-02	DRSLTR	Correspondence Related to Draft Registration Statement	https://www.sec.gov/Archives/edgar/data/1692830/000095012319006965/0000950123-19-006965-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1692830/000110465920021711/0001104659-20-021711-index.htm
2019-09-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000114420419044451/0001144204-19-044451-index.htm
2019-09-17	SC 13D	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1692830/000114420419044922/0001144204-19-044922-index.htm
2019-09-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000114420419044929/0001144204-19-044929-index.htm
2019-09-23	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1692830/000114420419045553/0001144204-19-045553-index.htm
2019-08-16	S-1	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1692830/000119312519223576/0001193125-19-223576-index.htm
2019-08-16	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1692830/000119312519223586/0001193125-19-223586-index.htm
2019-08-27	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1692830/000119312519231142/0001193125-19-231142-index.htm
2019-09-03	S-1/A	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1692830/000119312519235733/0001193125-19-235733-index.htm
2019-09-03	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1692830/000119312519235737/0001193125-19-235737-index.htm
2019-09-10	8-A12B	Registration of securities [Section 12(b)]	https://www.sec.gov/Archives/edgar/data/1692830/000119312519241950/0001193125-19-241950-index.htm
2019-09-10	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1692830/000119312519242128/0001193125-19-242128-index.htm
2019-09-11	S-1/A	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1692830/000119312519243034/0001193125-19-243034-index.htm
2019-09-12	S-1MEF	Registration adding securities to prior Form S-1 registration [Rule 462(b)]	https://www.sec.gov/Archives/edgar/data/1692830/000119312519244191/0001193125-19-244191-index.htm
2019-09-13	424B4	Prospectus [Rule 424(b)(4)]	https://www.sec.gov/Archives/edgar/data/1692830/000119312519244957/0001193125-19-244957-index.htm
2019-09-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1692830/000119312519246858/0001193125-19-246858-index.htm
2019-09-17	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1692830/000119312519246952/0001193125-19-246952-index.htm
2019-11-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1692830/000119312519289958/0001193125-19-289958-index.htm
2019-11-27	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1692830/000119312519302660/0001193125-19-302660-index.htm
2020-03-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1692830/000119312520068760/0001193125-20-068760-index.htm
2020-03-10	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1692830/000119312520068880/0001193125-20-068880-index.htm
2020-04-24	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1692830/000119312520119086/0001193125-20-119086-index.htm
2020-04-24	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1692830/000119312520119097/0001193125-20-119097-index.htm
2020-05-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1692830/000119312520140481/0001193125-20-140481-index.htm
2020-06-15	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1692830/000119312520169520/0001193125-20-169520-index.htm
2020-07-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1692830/000119312520188801/0001193125-20-188801-index.htm
2020-08-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1692830/000119312520216295/0001193125-20-216295-index.htm
2020-09-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1692830/000119312520243159/0001193125-20-243159-index.htm
2020-10-23	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1692830/000119312520275551/0001193125-20-275551-index.htm
2019-09-11	CERT	Certification	https://www.sec.gov/Archives/edgar/data/1692830/000135445719000443/0001354457-19-000443-index.htm
2019-09-18	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000138713119007014/0001387131-19-007014-index.htm
2019-09-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000138713119007016/0001387131-19-007016-index.htm
2020-02-13	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1692830/000138713120001540/0001387131-20-001540-index.htm
2019-11-12	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1692830/000156459019042959/0001564590-19-042959-index.htm
2020-03-10	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1692830/000156459020009753/0001564590-20-009753-index.htm
2020-05-12	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1692830/000156459020024703/0001564590-20-024703-index.htm
2020-08-11	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1692830/000156459020039324/0001564590-20-039324-index.htm
2020-03-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920005798/0001567619-20-005798-index.htm
2020-03-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920005799/0001567619-20-005799-index.htm
2020-03-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920005800/0001567619-20-005800-index.htm
2020-03-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920006202/0001567619-20-006202-index.htm
2020-03-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920006203/0001567619-20-006203-index.htm
2020-04-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920007501/0001567619-20-007501-index.htm
2020-04-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920008036/0001567619-20-008036-index.htm
2020-05-06	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920009164/0001567619-20-009164-index.htm
2020-05-06	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920009165/0001567619-20-009165-index.htm
2020-05-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920009166/0001567619-20-009166-index.htm
2020-05-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920010950/0001567619-20-010950-index.htm
2020-06-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920011564/0001567619-20-011564-index.htm
2020-06-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920011565/0001567619-20-011565-index.htm
2020-06-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012247/0001567619-20-012247-index.htm
2020-06-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012248/0001567619-20-012248-index.htm
2020-06-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012249/0001567619-20-012249-index.htm
2020-06-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012250/0001567619-20-012250-index.htm
2020-06-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012251/0001567619-20-012251-index.htm
2020-06-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012252/0001567619-20-012252-index.htm
2020-06-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012533/0001567619-20-012533-index.htm
2020-06-30	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012688/0001567619-20-012688-index.htm
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-07-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-07-07	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012995/0001567619-20-012995-index.htm
2020-07-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012996/0001567619-20-012996-index.htm
2020-08-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920014306/0001567619-20-014306-index.htm
2020-08-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920014527/0001567619-20-014527-index.htm
2020-09-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920016411/0001567619-20-016411-index.htm
2020-09-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1692830/000156761920016413/0001567619-20-016413-index.htm
2016-12-29	D	Notice of Exempt Offering of Securities	https://www.sec.gov/Archives/edgar/data/1692830/000169283016000001/0001692830-16-000001-index.htm
2018-02-12	D/A	Notice of Exempt Offering of Securities	https://www.sec.gov/Archives/edgar/data/1692830/000169283018000001/0001692830-18-000001-index.htm
2019-09-12	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1692830/999999999519002075/9999999995-19-002075-index.htm
2019-08-05	SEC STAFF	SEC Staff Letter: REDACTED EXHIBIT	https://www.sec.gov/Archives/edgar/data/1692830/999999999719006376/9999999997-19-006376-index.htm
2019-09-12	SEC STAFF	SEC Staff Letter: REDACTED EXHIBIT	https://www.sec.gov/Archives/edgar/data/1692830/999999999719006804/9999999997-19-006804-index.htm

Satsuma Pharmaceuticals, Inc (STSA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Satsuma Pharmaceuticals, Inc (STSA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1084%
Institutional Ownership: 5683%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2020-03-11	Thomas P. O'Neil	Chief Financial Officer	Sell	1,000.00	27.68	27,678.00	0.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920006202/0001567619-20-006202-index.htm
2020-05-20	Thomas P. O'Neil	Chief Financial Officer	Sell	2,000.00	25.00	50,000.00	0.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920010950/0001567619-20-010950-index.htm
2020-06-01	Thomas P. O'Neil	Chief Financial Officer	Sell	1,000.00	25.32	25,323.50	0.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920011564/0001567619-20-011564-index.htm
2020-06-23	Thomas P. O'Neil	Chief Financial Officer	Sell	2,115.00	35.23	74,511.87	0.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012533/0001567619-20-012533-index.htm
2020-07-01	Thomas P. O'Neil	Chief Financial Officer	Sell	300.00	25.63	7,690.20	0.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-07-01	Thomas P. O'Neil	Chief Financial Officer	Sell	394.00	26.70	10,520.08	0.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-07-01	Thomas P. O'Neil	Chief Financial Officer	Sell	306.00	27.59	8,443.64	0.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-08-05	Thomas P. O'Neil	Chief Financial Officer	Sell	1,000.00	25.00	25,000.00	0.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920014527/0001567619-20-014527-index.htm
2020-09-01	Thomas P. O'Neil	Chief Financial Officer	Sell	750.00	22.19	16,644.53	0.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920016411/0001567619-20-016411-index.htm
2020-03-11	Thomas P. O'Neil	Chief Financial Officer	Buy	1,000.00	4.56	4,560.00	1,000.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920006202/0001567619-20-006202-index.htm
2020-06-01	Thomas P. O'Neil	Chief Financial Officer	Buy	1,000.00	4.56	4,560.00	1,000.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920011564/0001567619-20-011564-index.htm
2020-08-05	Thomas P. O'Neil	Chief Financial Officer	Buy	1,000.00	4.56	4,560.00	1,000.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920014527/0001567619-20-014527-index.htm
2019-09-17	KEN TAKANASHI	Director	Buy	233,333.00	15.00	3,499,995.00	1,561,719.00	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023732/0000899243-19-023732-index.htm
2019-09-17	TPG Group Holdings (SBS) Advisors, Inc.	10% Share Holder	Buy	100,000.00	15.00	1,500,000.00	1,885,939.00	https://www.sec.gov/Archives/edgar/data/1692830/000138713119007016/0001387131-19-007016-index.htm
2020-05-20	Thomas P. O'Neil	Chief Financial Officer	Buy	2,000.00	4.56	9,120.00	2,000.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920010950/0001567619-20-010950-index.htm
2020-04-01	DETLEF ALBRECHT	Chief Medical Officer	Sell	200.00	20.25	4,049.00	20,012.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920007501/0001567619-20-007501-index.htm
2020-04-14	DETLEF ALBRECHT	Chief Medical Officer	Sell	800.00	20.00	16,000.00	20,012.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920008036/0001567619-20-008036-index.htm
2020-03-11	DETLEF ALBRECHT	Chief Medical Officer	Sell	1,000.00	27.42	27,422.40	20,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920006203/0001567619-20-006203-index.htm
2020-05-05	DETLEF ALBRECHT	Chief Medical Officer	Sell	1,000.00	20.00	20,000.00	20,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920009166/0001567619-20-009166-index.htm
2020-06-01	DETLEF ALBRECHT	Chief Medical Officer	Sell	1,000.00	25.26	25,256.90	20,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920011565/0001567619-20-011565-index.htm
2020-07-01	DETLEF ALBRECHT	Chief Medical Officer	Sell	300.00	25.69	7,707.33	20,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-07-01	DETLEF ALBRECHT	Chief Medical Officer	Sell	600.00	26.99	16,194.72	20,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-07-01	DETLEF ALBRECHT	Chief Medical Officer	Sell	100.00	27.81	2,781.00	20,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-08-03	DETLEF ALBRECHT	Chief Medical Officer	Sell	800.00	22.85	18,281.60	20,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920014306/0001567619-20-014306-index.htm
2020-08-03	DETLEF ALBRECHT	Chief Medical Officer	Sell	200.00	23.12	4,624.02	20,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920014306/0001567619-20-014306-index.htm
2020-09-01	DETLEF ALBRECHT	Chief Medical Officer	Sell	1,000.00	22.21	22,210.00	20,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920016413/0001567619-20-016413-index.htm
2020-07-01	DETLEF ALBRECHT	Chief Medical Officer	Buy	100.00	4.56	456.00	20,312.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-04-01	DETLEF ALBRECHT	Chief Medical Officer	Buy	200.00	4.56	912.00	20,412.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920007501/0001567619-20-007501-index.htm
2020-08-03	DETLEF ALBRECHT	Chief Medical Officer	Buy	200.00	4.56	912.00	20,412.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920014306/0001567619-20-014306-index.htm
2020-07-01	DETLEF ALBRECHT	Chief Medical Officer	Buy	300.00	4.56	1,368.00	20,512.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-04-14	DETLEF ALBRECHT	Chief Medical Officer	Buy	800.00	4.56	3,648.00	20,812.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920008036/0001567619-20-008036-index.htm
2020-07-01	DETLEF ALBRECHT	Chief Medical Officer	Buy	600.00	4.56	2,736.00	20,812.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-08-03	DETLEF ALBRECHT	Chief Medical Officer	Buy	800.00	4.56	3,648.00	21,012.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920014306/0001567619-20-014306-index.htm
2020-06-23	Thomas P. O'Neil	Chief Financial Officer	Buy	2,115.00	1.04	2,199.60	2,115.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012533/0001567619-20-012533-index.htm
2020-03-11	DETLEF ALBRECHT	Chief Medical Officer	Buy	1,000.00	4.56	4,560.00	21,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920006203/0001567619-20-006203-index.htm
2020-05-05	DETLEF ALBRECHT	Chief Medical Officer	Buy	1,000.00	4.56	4,560.00	21,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920009166/0001567619-20-009166-index.htm
2020-06-01	DETLEF ALBRECHT	Chief Medical Officer	Buy	1,000.00	4.56	4,560.00	21,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920011565/0001567619-20-011565-index.htm
2020-09-01	DETLEF ALBRECHT	Chief Medical Officer	Buy	1,000.00	4.56	4,560.00	21,212.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920016413/0001567619-20-016413-index.htm
2020-07-01	Thomas P. O'Neil	Chief Financial Officer	Buy	300.00	4.56	1,368.00	300.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-07-01	Thomas P. O'Neil	Chief Financial Officer	Buy	306.00	4.56	1,395.36	306.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-07-01	Thomas P. O'Neil	Chief Financial Officer	Buy	394.00	4.56	1,796.64	394.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2019-09-17	Rajeev M. Shah	Director	Buy	1,140,946.00	15.00	17,114,190.00	4,489,471.00	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023733/0000899243-19-023733-index.htm
2019-09-17	RA CAPITAL MANAGEMENT, LLC	Director	Buy	1,333,333.00	15.00	19,999,995.00	4,681,858.00	https://www.sec.gov/Archives/edgar/data/1692830/000114420419044929/0001144204-19-044929-index.htm
2019-09-17	Rajeev M. Shah	Director	Buy	192,387.00	15.00	2,885,805.00	4,681,858.00	https://www.sec.gov/Archives/edgar/data/1692830/000089924319023733/0000899243-19-023733-index.htm
2020-09-01	Thomas P. O'Neil	Chief Financial Officer	Buy	750.00	4.56	3,420.00	750.00	https://www.sec.gov/Archives/edgar/data/1692830/000156761920016411/0001567619-20-016411-index.htm

Satsuma Pharmaceuticals, Inc

(NASDAQ:STSA)